Carlos Bonilla
Corporate Officer/Principal en Carlos J. Bonilla & Associates PL .
Fortuna: 1 M $ al 31/05/2024
Perfil
Carlos J.
Bonilla is currently the Principal of Mr. Bonilla & Associates PL.
Previously, he worked as a Director at XenaCare Holdings, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LA ROSA HOLDINGS CORP.
6.82% | 16/04/2024 | 1 010 840 ( 6.82% ) | 1 M $ | 31/05/2024 |
Cargos activos de Carlos Bonilla
| Empresas | Cargo | Inicio |
|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 12/05/2011 |
Antiguos cargos conocidos de Carlos Bonilla.
| Empresas | Cargo | Fin |
|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
- Bolsa de valores
- Insiders
- Carlos Bonilla
